These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24497196)

  • 1. Synthesis and biological evaluation of 10-(11) C-dihydrotetrabenazine as a vesicular monoamine transporter 2 radioligand.
    Li X; Chen Z; Tang J; Liu C; Zou P; Huang H; Tan C; Yu H
    Arch Pharm (Weinheim); 2014 May; 347(5):313-9. PubMed ID: 24497196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters].
    Quincoces G; Collantes M; Catalán R; Ecay M; Prieto E; Martino E; Blesa FJ; Alvarez-Erviti L; Areses P; Arbizu J; Obeso JA; Martí-Climent JM; Richter JA; Peñuelas I
    Rev Esp Med Nucl; 2008; 27(1):13-21. PubMed ID: 18208777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [
    Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR; Tsai CL; Huang YY; Shiue CY; Tzen KY; Yen RF; Hsin LW
    PLoS One; 2016; 11(9):e0161295. PubMed ID: 27612194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deuterated
    Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VMAT2 imaging agent, D6-[
    Zhao R; Zha Z; Yao X; Ploessl K; Choi SR; Liu F; Zhu L; Kung HF
    Nucl Med Biol; 2019; 72-73():26-35. PubMed ID: 31330409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
    Zheng P; Lieberman BP; Choi SR; Plöessl K; Kung HF
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3435-8. PubMed ID: 21531556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
    Xu Y; Tang J; Liu C; Zhao C; Cao S; Yu H; Chen Z; Xie M
    Nucl Med Biol; 2021; 96-97():9-18. PubMed ID: 33647803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2.
    Zhu L; Liu J; Kung HF
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5026-8. PubMed ID: 19632829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
    Kilbourn MR; Hockley B; Lee L; Hou C; Goswami R; Ponde DE; Kung MP; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):233-7. PubMed ID: 17383572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.
    Sossi V; Holden JE; Topping GJ; Camborde ML; Kornelsen RA; McCormick SE; Greene J; Studenov AR; Ruth TJ; Doudet DJ
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1407-15. PubMed ID: 17245418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
    Boileau I; Rusjan P; Houle S; Wilkins D; Tong J; Selby P; Guttman M; Saint-Cyr JA; Wilson AA; Kish SJ
    J Neurosci; 2008 Sep; 28(39):9850-6. PubMed ID: 18815269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
    PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatization of (±) dihydrotetrabenazine for copper-64 labeling towards long-lived radiotracers for PET imaging of the vesicular monoamine transporter 2.
    Kumar A; Lo ST; Öz OK; Sun X
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5663-5665. PubMed ID: 25467156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans.
    Boileau I; Houle S; Rusjan PM; Furukawa Y; Wilkins D; Tong J; Selby P; Wilson AA; Kish SJ
    Synapse; 2010 Jun; 64(6):417-20. PubMed ID: 20169578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain.
    Chen Z; Tang J; Liu C; Li X; Huang H; Xu X; Yu H
    Nucl Med Biol; 2016 Jan; 43(1):124-129. PubMed ID: 26526872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.
    Narendran R; Jedema HP; Lopresti BJ; Mason NS; Himes ML; Bradberry CW
    Biol Psychiatry; 2015 Mar; 77(5):488-92. PubMed ID: 25062684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.